Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2013

Sysorex Global Holdings Corp. (SYRX) Starts Presentation at Rodman & Renshaw Global Investment Conference

Sysorex Global Holdings  is a leading information technology solutions and integration company. The company delivers specialized custom technology solutions, cyber security assessments and resolutions, data analytics, BYOD (bring-your-own-device) solutions, Enterprise Architecture Design, and Project and Program Management to its clients. … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Opexa Therapeutics, Inc. (OPXA) Starts Presentation at Rodman & Renshaw Global Investment Conference

Opexa Therapeutics is a biopharmaceutical company that develops personalized cellular therapies for the treatment of multiple sclerosis. Based on the company’s own T-cell technology, its leading product candidates have been through clinical trials to test their effectiveness in treating patients … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Miller Energy Resources, Inc. (MILL) Starts Presentation at Rodman & Renshaw Global Investment Conference

Miller Energy Resources is engaged in the discovery, development, and operation of oil and gas wells throughout east Tennessee’s Appalachian region, as well as areas of south-central Alaska. The independent exploration and production company owns hundreds of thousands of acres … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Safeguard Scientifics, Inc. (SFE) Starts Presentation at Rodman & Renshaw Global Investment Conference

Safeguard Scientifics provides capital and operational support to entrepreneurs with a continuous flow and extensive range of marketing innovations in the Health and Technology industries. The Company was instrumental in negotiating more than 100 Mergers & Acquisitions and over 20 … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Northwest Biotherapeutics, Inc. (NWBO) Extends Patent Portfolio

Northwest Biotherapeutics is a biotechnology focused on developing personalized immunotherapy products to treat solid tumor cancers more effectively than currently available treatments. The goal for its therapies is to treat cancer without the toxicities associated with chemotherapies and do it … Continue reading

Posted in Small Cap News | Leave a comment

pSivida Corp. (PSDV) Starts Presentation at Rodman & Renshaw Global Investment Conference

pSivida is a company focused on the treatment of eye diseases, specifically diseases that affect the back of the eye. The company and its subsidiaries develop drug deliver products that can be administered by implantation, injection, or insertion. It has … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Elephant Talk Communications Corp. (ETAK) Realizes Revenue from Recently Signed Iusacell Contract

Elephant Talk Communications announced it has begun recognizing revenue from its recently signed five-year contract with Mexico-based mobile network operator Iusacell. Having finalized the installation phase, Elephant Talk is now shifting its focus toward implementing and initiating service for Iusacell … Continue reading

Posted in Small Cap News | Leave a comment

Anika Therapeutics, Inc. (ANIK) Starts Presentation at Rodman & Renshaw Global Investment Conference

Anika Therapeutics is a leader in developing, manufacturing and commercializing therapeutic products for tissue protection, healing and repair. The company’s products are based on hyaluronic acid (HA), which is a naturally occurring, biocompatible polymer found throughout the body. The company’s … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Neuralstem, Inc. (CUR) Starts Presentation at Rodman & Renshaw Global Investment Conference

Neuralstem is a biopharmaceutical company out of Rockville, Maryland, that specializes in the development and commercialization of treatments for diseases related to the central nervous system. Its innovative technology allows for the isolation of human stem cells to enable generation … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Spectrum Pharmaceuticals, Inc. (SPPI) Starts Presentation at Rodman & Renshaw Global Investment Conference

Spectrum Pharmaceuticals is a leading global biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in oncology and hematology. Spectrum and its affiliates market three oncology drugs: FUSILEV® for Injection in the U.S.; FOLOTYN®, which … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment